Pharmaceutical Industry Size, Share, Opportunities and Outlook 2019
3 pages
English

Pharmaceutical Industry Size, Share, Opportunities and Outlook 2019

-

Le téléchargement nécessite un accès à la bibliothèque YouScribe
Tout savoir sur nos offres
3 pages
English
Le téléchargement nécessite un accès à la bibliothèque YouScribe
Tout savoir sur nos offres

Description

The key priorities forecast in the business structure for global pharmaceutical industry executives in H1 2016 (April-September 2016) are new product development and improving operational efficiency.

Informations

Publié par
Publié le 22 février 2017
Nombre de lectures 1
Langue English

Extrait




Pharmaceutical Industry Share, Analysis and
Overview, Business Confidence Report 2016
“The pharmaceutical industry is expected to record
higher expenditure towards new product
development and mergers and acquisitions in H2
2016 as compared to H1 2016. Moreover,
executives with business operations in the
AsiaPacific and Europe expect increase in raw material
prices in H2 2016 as compared to H1 2016. ”


Summary
The existing economic environment is stable for the pharmaceutical industry, and customer
confidence levels will remain constant in H2 2016 (July 2016-December 2016). Companies are
slightly optimistic about economic conditions in North America and the Asia-Pacific due to positive
momentum in the US, firm domestic demand, and strong government expenditure in India. The
pharmaceutical industry is expected to record higher expenditure towards new product development
and mergers and acquisitions in H2 2016 as compared to H1 2016. Moreover, executives with
business operations in the Asia-Pacific and Europe expect increase in raw material prices in H2 2016
as compared to H1 2016.
Browse Complete Summary Click Here @

http://www.radiantinsights.com/research/pharmaceutical-industry-business-confidencereport-h2-2016
Key Findings
- Economic environment is more favorable in Eastern Europe and Australasia in H2 2016 as
compared to H1 2016

Follow Us:

- The majority of respondents communicated optimism about company and industry growth
prospects for the next six months
- Globally, supplier prices of ingredients are anticipated to increase by 2.5% over the next six
months
- Survey results indicate highest increase in spending on new product development in H2 2016 as
compared to H1 2016
- Respondents with business operations in Asia-Pacific are more concerned about the performance of
developing economies in H2 2016 as compared to H1 2016
- Organizations intend to focus on new product development and improving operational efficiency
during the next six months
Synopsis
Radiant Insights's pharmaceutical Industry Business Confidence Survey H2 2016 examines
executives' opinion on the business environment over July-December 2016. It also highlights
existing economic conditions, supplier price variations, sales performance, industry and company
growth outlook, spending patterns, and key priorities. Additionally, the report provides information
categorized by region and presents comparison with H1 2016 wherever applicable.
Request A Sample Copy Of This Report @

http://www.radiantinsights.com/research/pharmaceutical-industry-business-confidencereport-h2-2016/request-sample
What else does this report offer?
- Current state of the global economy: examines prevailing economic conditions globally and across
various regions
- Company and industry growth outlook: provides industry executives' expectations towards the
growth prospects of their company and the industry over the next six months
- Change in customer confidence: analyzes pharmaceutical industry executives' opinion about the
change in customer confidence during H2 2016
- Supplier prices projection: determines expected change in supplier prices across various categories
and their impact on business confidence
- Change in staff headcount and sales performance: tracks expected change in staff headcount and
sales for H2 2016 among industry executives globally
- Significant investment activities: highlights various areas in which industry executives intend to
invest over the next six months

Follow Us:

- Business concerns: provides information about potential business concerns indicated by survey
respondents for H1 2016
- Key priorities: identifies the top priorities of industry executives operating in various regions
See More Reports of This Category by Radiant Insights @
http://www.radiantinsights.com/catalog/pharmaceutical
About Radiant Insights, Inc:
Radiant Insights is a platform for companies looking to meet their market
research and business intelligence requirements. We assist and facilitate
organizations and individuals procure market research reports, helping them in
the decision making process. We have a comprehensive collection of reports,
covering over 40 key industries and a host of micro markets. In addition to over
extensive database of reports, our experienced research coordinators also offer a
host of ancillary services such as, research partnerships/ tie-ups and customized
research solutions.
Contact Details:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
28 2nd Street, Suite 3036, San Francisco, CA 94105, United States
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
Web: http://www.radiantinsights.com/

Visit Our Blog: http://marketresearchreportandforecast.blogspot.in/



Follow Us:

  • Univers Univers
  • Ebooks Ebooks
  • Livres audio Livres audio
  • Presse Presse
  • Podcasts Podcasts
  • BD BD
  • Documents Documents